CYP27A1 and cancer: With regard to cancer staging, the CTx+ group consisted of one stage I patient, three stage II patients, eight stage III patients, and one stage IV patient who went through oxaliplatin+Xeloda or tegafur+gemaracil chemotherapy regimens.